Dr Anurag Saxena

Dr Anurag Saxena is a Consultant Paediatric Neurologist and expert witness at Noah's Ark Children's Hospital for Wales, where he also serves as Clinical Lead for the Paediatric Neurorehabilitation Team. His principal areas of clinical expertise include acquired brain injury, paediatric stroke, epilepsy, neurodisability, neurogenetic disorders and Tuberous Sclerosis Complex, with particular interest in the long-term neurological outcomes of childhood neurological disease and injury.

His current clinical practice centres on the assessment, diagnosis and management of children with complex neurological conditions requiring specialist tertiary care. He leads multidisciplinary neurorehabilitation services for children recovering from acquired brain and spinal cord injury and paediatric stroke, while also providing specialist care for children with complex epilepsy, neurovascular disorders and neurodevelopmental conditions. As a key clinician within the All-Wales Tuberous Sclerosis Complex service, he has extensive experience managing children with this rare condition and its associated neurological manifestations.

In addition to his clinical leadership, Dr Saxena is an Honorary Senior Research Fellow at Cardiff University and has led clinical research into novel treatments for Tuberous Sclerosis Complex-related epilepsy. His combination of specialist clinical practice, neurorehabilitation expertise and research leadership enables him to provide authoritative opinions across a broad spectrum of complex paediatric neurological conditions.

Dr Anurag Saxena has undertaken medico-legal practice since 2019, providing independent expert opinion in complex paediatric neurology cases. He accepts instructions in clinical negligence and personal injury claims, with particular expertise in acquired brain injury, paediatric stroke, neurovascular disorders, complex and genetic epilepsies, neurodisability and Tuberous Sclerosis Complex. He prepares breach of duty, causation, and condition and prognosis reports, delivering clear, objective opinions supported by his extensive specialist clinical experience. His role as Clinical Lead for Paediatric Neurorehabilitation provides additional expertise in assessing long-term neurological outcomes, functional recovery and rehabilitation following childhood neurological injury. Dr Saxena's reports are evidence based, balanced and focused on assisting solicitors in understanding complex neurological issues affecting children and young people.

Dr Saxena's current clinical practice focuses on the assessment, diagnosis and long-term management of children with complex neurological conditions requiring specialist tertiary care, particularly those with acquired brain injury, paediatric stroke and neurovascular disorders. He leads the multidisciplinary neurorehabilitation of children recovering from traumatic, hypoxic and inflammatory brain injury, as well as spinal cord injury, with a strong emphasis on maximising functional recovery, managing neurological impairment and supporting long-term rehabilitation.

A significant proportion of his work involves caring for children with complex and treatment-resistant epilepsies, including genetic epilepsy syndromes such as SCN1A-related disorders and Dravet syndrome, alongside children with neurogenetic and neurodevelopmental disorders. He has particular expertise in Tuberous Sclerosis Complex, where his practice encompasses the neurological management of epilepsy, neurodevelopmental complications and the application of emerging therapies informed by clinical research. His clinical interests also include the assessment of cognitive, functional and developmental outcomes following neurological injury, with extensive experience managing spasticity, tone disorders and the long-term neurological sequelae of childhood brain injury. His practice combines specialist diagnostic expertise with coordinated multidisciplinary rehabilitation to optimise outcomes for children with complex neurological conditions. 

Dr Saxena is an Honorary Senior Research Fellow at Cardiff University with a PhD and an active research portfolio in paediatric neurology. He has served as Principal Investigator for a clinical trial evaluating Epidyolex in Tuberous Sclerosis Complex-related epilepsy and Clinical Lead for the TRON Phase II trial investigating Everolimus, alongside contributing to published research in the field.